Product Comparison


  Sanofi Pasteur 63361024315 Sanofi Pasteur 63361024310
McKesson # 1195619 1195617
Description Vaxelis™ DTaP, Polio, Hib, and Hepatitis B Vaccine Indicated for People 6 Weeks to 4 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine Injection Prefilled Syringe 0.5 mL Vaxelis™ DTaP, Polio, Hib, and Hepatitis B Vaccine Indicated for People 6 Weeks Through 4 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine Injection Single-Dose Vial 0.5 mL
Manufacturer # 6336102431563361024310
Brand Vaxelis™Vaxelis™
Manufacturer Sanofi PasteurSanofi Pasteur
Invoice VAXELIS DTAP-IPV/HIB/HEB, PFS 0.5ML (10/CT)VAXELIS DTAP-IPV/HIB/HEPB, SDV0.5ML (10/CT)
    Log In to Order   Log In to Order

Comparison

Container Type Prefilled SyringeSingle-Dose Vial
Generic Drug Code 4893640619
NDC Number 6336102431563361024310
User Indicated for People 6 Weeks to 4 Years of AgeIndicated for People 6 Weeks Through 4 Years of Age
Application DTaP, Polio, Hib, and Hepatitis B VaccineDTaP, Polio, Hib, and Hepatitis B Vaccine
Country of Origin CanadaCanada
Dosage Form InjectionInjection
Generic Drug Name Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B VaccineDiphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires Refrigeration
Strength 15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL
Type IntramuscularIntramuscular
UNSPSC Code 5120210151202101
Volume 0.5 mL0.5 mL
Features and Benefits
  • VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
  • VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
  • VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit